Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections (Q30443179)

9 November 2017

Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections (English)

1 reference

9 November 2017

Pseudomonas aeruginosa

0 references

0 references

1 reference

7

1 reference

9 November 2017

Antonio DiGiandomenico

1

1 reference

9 November 2017

Jayasimha Rao

2

1 reference

9 November 2017

Katie Harcher

3

1 reference

9 November 2017

Tanweer S Zaidi

4

1 reference

9 November 2017

Jason Gardner

5

1 reference

9 November 2017

Alice N Neely

6

1 reference

9 November 2017

Joanna B Goldberg

8

1 reference

9 November 2017

language of work or name

English

0 references

publication date

5 March 2007

1 reference

Proceedings of the National Academy of Sciences of the United States of America

9 November 2017

1 reference

9 November 2017

104

1 reference

9 November 2017

11

1 reference

9 November 2017

4624-4629

1 reference

Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.

9 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Oral vaccination of BALB/c mice with Salmonella enterica serovar Typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

O-Antigen Serotypes and Type III Secretory Toxins in Clinical Isolates of Pseudomonas aeruginosa

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Pseudomonas aeruginosa galU is required for a complete lipopolysaccharide core and repairs a secondary mutation in a PA103 (serogroup O11) wbpM mutant

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Regional specialization in the mucosal immune system: what happens in the microcompartments?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Cystic fibrosis transmembrane conductance regulator-mediated corneal epithelial cell ingestion of Pseudomonas aeruginosa is a key component in the pathogenesis of experimental murine keratitis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838651

Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics

14 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0608657104

Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0608657104

Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0608657104

Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0608657104

Integration-proficient Pseudomonas aeruginosa vectors for isolation of single-copy chromosomal lacZ and lux gene fusions

21 January 2018

1 reference

12 December 2020

Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis

1 reference

12 December 2020

Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group

1 reference

12 December 2020

Circulating levels of tumour necrosis factor, interleukin 6 and proteolytic activity in a murine model of burn and infection

1 reference

12 December 2020

Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection

1 reference

12 December 2020

Intranasal immunisation with conjugate vaccine protects mice from systemic and respiratory tract infection with Pseudomonas aeruginosa

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0608657104

1 reference

9 November 2017

0 references

1 reference

9 November 2017

1 reference